+1 Recommend
1 collections
      • Record: found
      • Abstract: found
      • Article: found

      Glucocorticoid-Induced Osteoporosis: From Basic Mechanisms to Clinical Aspects

      Read this article at

          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.


          Glucocorticoid (GC)-induced osteoporosis (GCOP) is the most common cause of osteoporosis in adults aged 20–45 years as well as the most common cause of iatrogenic osteoporosis. GC excess, either endogenous or exogenous, induces bone loss in 30–50% of cases. Indeed, bone loss leading to fractures is perhaps the most incapacitating, sometimes partially irreversible, complication of GC therapy. Nevertheless, GCOP is often underdiagnosed and left untreated. The following article provides an update on the cellular and molecular mechanisms implicated in the pathophysiology of GC-induced bone loss, as well as some guidelines on diagnostic, preventive and therapeutic strategies for this medical condition, in an effort to promote a better knowledge and greater awareness of GCOP by both the patient and the physician.

          Related collections

          Most cited references 158

          • Record: found
          • Abstract: not found
          • Article: not found

          Consensus development conference: diagnosis, prophylaxis, and treatment of osteoporosis.

            • Record: found
            • Abstract: not found
            • Article: not found

            Nontraumatic necrosis of bone (osteonecrosis).

             H Mankin (1992)
              • Record: found
              • Abstract: not found
              • Article: not found

              Birth and Death of Bone Cells: Basic Regulatory Mechanisms and Implications for the Pathogenesis and Treatment of Osteoporosis

               S C Manolagas (2000)

                Author and article information

                S. Karger AG
                March 2005
                07 March 2005
                : 12
                : 1
                : 1-19
                aClinical Neuroendocrinology Branch, National Institute of Mental Health and bPediatric and Reproductive Endocrinology Branch, National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, Md., USA; cDepartment of Pharmacology, Faculty of Medicine, University of Patras, Patras, Greece
                82360 Neuroimmunomodulation 2005;12:1–19
                © 2005 S. Karger AG, Basel

                Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher. Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug. Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.

                Page count
                Figures: 1, Tables: 1, References: 258, Pages: 19


                Comment on this article